New president and CEO appointed at Active Biotech
This article was originally published in Scrip
Executive Summary
Tomas Leanderson has been named president and CEO of Active Biotech (Sweden). He will succeed Sven Andréasson, who has resigned from the company effective September 1st. Mr Leanderson has been the company's chief scientific officer since 1999.